Cannell Capital - GRACELL BIOTECHNOLOGIES INC ownership

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 36 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell Capital ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2023$26,596
-19.1%
14,2990.0%0.01%
-28.6%
Q4 2022$32,888
-28.5%
14,2990.0%0.01%
-36.4%
Q3 2022$46,000
+283.3%
14,299
+553.2%
0.01%
+450.0%
Q2 2022$12,0002,1890.00%
Other shareholders
GRACELL BIOTECHNOLOGIES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 3,445,973$8,029,0000.68%
Paradigm Biocapital Advisors LP 783,445$1,825,0000.48%
Orbimed Advisors 7,884,870$18,372,0000.30%
Vivo Capital, LLC 961,359$2,240,0000.15%
EcoR1 Capital, LLC 1,559,710$3,634,0000.11%
Temasek Holdings (Private) Ltd 9,901,940$23,071,5200.10%
Capital International, Inc./CA/ 2,335,476$5,442,0000.06%
Virtus ETF Advisers LLC 24,728$58,0000.03%
Capital International Sarl 228,149$532,0000.03%
FEDERATED HERMES, INC. 1,298,578$3,026,0000.01%
View complete list of GRACELL BIOTECHNOLOGIES INC shareholders